Hyperglycaemia as Cardiovascular Risk in Type 2 Diabetes

Abstract #415 Peripheral Arterial Disease and Its Association with Cardiovascular Risk Factors in Type 2 Diabetes

Endocrine Practice ◽

10.1016/s1530-891x(20)47176-9 ◽

2018 ◽

Vol 24 ◽

pp. 103-104

Author(s):

Rohit Kapoor ◽

Shivam Kapoor ◽

Rishabh Kapoor

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Peripheral Arterial Disease ◽

Cardiovascular Risk Factors ◽

Arterial Disease ◽

Peripheral Arterial

Download Full-text

Abstract #414 Ambulatory Blood Pressure Monitoring and Correlation with Cardiovascular Risk Markers in Type 2 Diabetes In Association with The Prevalence of Non-Dippers

Endocrine Practice ◽

10.1016/s1530-891x(20)47175-7 ◽

2018 ◽

Vol 24 ◽

pp. 103

Author(s):

Rohit Kapoor ◽

Shivam Kapoor ◽

Rishabh Kapoor

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Ambulatory Blood Pressure Monitoring ◽

Ambulatory Blood Pressure ◽

Blood Pressure Monitoring ◽

Risk Markers ◽

Pressure Monitoring

Download Full-text

Abstract #412 Impact of High Fibre Diet on Cardiovascular Risk Markers in Comorbidity of Hypertension and Type 2 Diabetes

Endocrine Practice ◽

10.1016/s1530-891x(20)47173-3 ◽

2018 ◽

Vol 24 ◽

pp. 102

Author(s):

Rohit Kapoor ◽

Shivam Kapoor ◽

Rishabh Kapoo

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Markers ◽

High Fibre Diet ◽

Fibre Diet ◽

High Fibre

Download Full-text

Empagliflozin improves glycemic parameters and cardiovascular risk factors in patients with Type 2 Diabetes (T2DM): Pooled data from four pivotal phase III trials

Diabetologie und Stoffwechsel ◽

10.1055/s-0034-1374999 ◽

2014 ◽

Vol 9 (S 01) ◽

Cited By ~ 13

Author(s):

T Hach ◽

J Gerich ◽

A Salsali ◽

G Kim ◽

S Hantel ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Phase Iii ◽

Pivotal Phase ◽

Pooled Data ◽

Phase Iii Trials

Download Full-text

Significant impact of the presence of type 2 diabetes on the cardiovascular risk conferred by the plasminogen activator inhibitor-1–675 5G/4G polymorphism

Diabetologie und Stoffwechsel ◽

10.1055/s-2007-984788 ◽

2007 ◽

Vol 2 (04) ◽

Author(s):

A Muendlein ◽

CH Saely ◽

T Marte ◽

L Koch ◽

F Schmid ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Plasminogen Activator ◽

Plasminogen Activator Inhibitor ◽

Plasminogen Activator Inhibitor 1 ◽

Activator Inhibitor

Download Full-text

Cardiovascular Risk Prediction in Type 2 Diabetes Patients

Medical Connections ◽

10.33311/medcon.2016.40.4.3 ◽

2016 ◽

Vol 40 (4/2016) ◽

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Risk Prediction ◽

Cardiovascular Risk Prediction ◽

Diabetes Patients

Download Full-text

Association of plasma testosterone concentration with cardiovascular risk factors in young Chinese men of type 2 diabetes mellitus

Endocrine Abstracts ◽

10.1530/endoabs.32.p393 ◽

2013 ◽

Author(s):

Xin Li ◽

Miao Yang ◽

Yuwen Wu ◽

SuXin Sun

Keyword(s):

Diabetes Mellitus ◽

Risk Factors ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Plasma Testosterone ◽

Chinese Men ◽

Testosterone Concentration

Download Full-text

B-type natriuretic peptide: a biomarker of cardiovascular risk in type 2 diabetes.

Endocrine Abstracts ◽

10.1530/endoabs.56.p295 ◽

2018 ◽

Author(s):

Ibtissem Oueslati ◽

Nadia Khessairi ◽

Emna Talbi ◽

Meriem Yazidi ◽

Fatma Chaker ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Natriuretic Peptide

Download Full-text

2259-PUB: Aging, Systolic Hypertension, Obesity, and Hyperuricemia Increase the Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus in Northwest China

Diabetes ◽

10.2337/db20-2259-pub ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 2259-PUB

Author(s):

QINGBIN ZHAO

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Risk ◽

Systolic Hypertension ◽

Northwest China

Download Full-text

Faculty Opinions recommendation of Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1058971.510928 ◽

2007 ◽

Author(s):

Henry Burger

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Hormone Replacement Therapy ◽

Replacement Therapy ◽

Glucose Homeostasis ◽

Low Dose ◽

Hormone Replacement

Download Full-text